Week 48 results of AMBER: A Phase 3, randomised, double-blind trial in ART-naïve HIV-1-infected adults to evaluate the efficacy and safety of DRV/Cobi/FTC/TAF versus DRV/Cobi plus FTC/TDF
2019 ◽
Vol 12
(1)
◽
pp. 48-54
2011 ◽
Vol 5
(S1)
◽
pp. 269-270
1997 ◽
Vol 171
(1)
◽
pp. 73-77
◽
Keyword(s):
2012 ◽
Vol 2012
◽
pp. 111-113
Keyword(s):
Keyword(s):